Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-28

Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial completed evaluating the effectiveness and safety of paliperidone palmitate in adults with acute schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INVEGA SUSTENNA (PALIPERIDONE PALMITATE)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED